Skip to Content
Merck
CN

C7165

Citrate-phosphate-dextrose solution

aseptically filled

Synonym(s):

Citrate-phosphate-glucose

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

NACRES:
NA.25
UNSPSC Code:
12161700

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Citrate-phosphate-dextrose solution, aseptically filled

sterility

aseptically filled

form

liquid

pH

5.2-5.8

storage temp.

2-8°C

Quality Level

200

Related Categories

Application

Citrate-phosphate-dextrose solution has been used as an anti-coagulant in bovine blood. It has also been used in the storage of fluorescein isothiocyanate (FITC) labeled erythrocytes. Citrate-phosphate-dextrose solution is suitable for erythrocyte survival studies and whole blood storage.

General description

Citrate-phosphate-dextrose solution (CPD) is an anticoagulant solution. It has 15% less citrate ion over citrate-phosphate-dextrose solution with adenine (ACD) and provides improved isotonicity, oxygen release function and posttransfusion viability for red blood cells.

Other Notes

Suggested anticoagulant: whole blood ratio: 1:14

Storage Class

10 - Combustible liquids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000442412
0000442412
0000373446
0000344575
0000342238

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

  1. Which document(s) contains shelf-life or expiration date information for a given product?

    If available for a given product, the recommended re-test date or the expiration date can be found on the Certificate of Analysis.

  2. How do I get lot-specific information or a Certificate of Analysis?

    The lot specific COA document can be found by entering the lot number above under the "Documents" section.

  3. How do I find price and availability?

    There are several ways to find pricing and availability for our products. Once you log onto our website, you will find the price and availability displayed on the product detail page. You can contact any of our Customer Sales and Service offices to receive a quote.  USA customers:  1-800-325-3010 or view local office numbers.

  4. What is the Department of Transportation shipping information for this product?

    Transportation information can be found in Section 14 of the product's (M)SDS.To access the shipping information for this material, use the link on the product detail page for the product. 

  5. For the anticoagulant Product C7165, Citrate-Phosphate-Dextrose solution, what is the proper anticoagulant to whole blood ratio to use?

    Our search of the literature shows that Citrate-Phosphate-Dextrose solution is typically used at a ratio of 1:7 or 1:9, but we do indeed test it at 1:14...the thinking being that if it works at 1:14, it will surely work at 1:7 or 1:9. The description of Product C7165, Citrate-Phosphate-Dextrose solution, suggests using it at an anticoagulant to whole blood ratio of 1.4 to 10 (about 1:7), but the specification sheet shows that it is tested at an anticoagulant to whole blood ratio of 1:14.

  6. My question is not addressed here, how can I contact Technical Service for assistance?

    Ask a Scientist here.

C1-inhibitor reduces hepatic leukocyte-endothelial interaction and the expression of VCAM-1 in LPS-induced sepsis in the rat
Croner RS, et al.
Microvascular Research, 67(2), 182-191 (2004)
Citrate phosphate dextrose (CPD) anticoagulant in blood transfusion
McCullough J and Weiblen BJ
Minnesota Medicine, 56(11), 980-982 (1973)
Alexander P Duryea et al.
IEEE transactions on ultrasonics, ferroelectrics, and frequency control, 62(12), 2068-2078 (2015-12-17)
Remanent bubble nuclei generated by primary cavitation collapse can limit the efficiency of histotripsy softtissue fractionation. When these residual bubbles persist from one histotripsy pulse to the next, they can seed the repetitive nucleation of cavitation bubbles at a discrete
Real-time feedback of histotripsy thrombolysis using bubble-induced color Doppler
Zhang X, et al.
Ultrasound in Medicine & Biology, 41(5), 1386-1401 (2015)
Noninvasive thrombolysis using histotripsy beyond the intrinsic threshold (microtripsy)
Zhang X, et al.
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control, 62(7), 1342-1355 (2015)
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service